Systematic antibody generation and validation via tissue microarray technology leading to identification of a novel protein prognostic panel in breast cancer.
about
Identification of the oncogenic kinase TOPK/PBK as a master mitotic regulator of C2H2 zinc finger proteinsEarly biomarkers of joint damage in rheumatoid and psoriatic arthritisTranscriptome sequencing identifies ANLN as a promising prognostic biomarker in bladder urothelial carcinoma.TOPK is highly expressed in circulating tumor cells, enabling metastasis of prostate cancerTransgelin gene is frequently downregulated by promoter DNA hypermethylation in breast cancer.ANLN is a prognostic biomarker independent of Ki-67 and essential for cell cycle progression in primary breast cancer.The potent tumor suppressor miR-497 inhibits cancer phenotypes in nasopharyngeal carcinoma by targeting ANLN and HSPA4L.PBK/TOPK Expression Predicts Prognosis in Oral CancerPhosphorylation of TOPK at Y74, Y272 by Src increases the stability of TOPK and promotes tumorigenesis of colonLow level of PDZ domain containing 1 (PDZK1) predicts poor clinical outcome in patients with clear cell renal cell carcinomaOverexpression of PBK/TOPK relates to tumour malignant potential and poor outcome of gastric carcinoma.TOPK inhibitor induces complete tumor regression in xenograft models of human cancer through inhibition of cytokinesis.Knockdown of ANLN by lentivirus inhibits cell growth and migration in human breast cancer.Infrared imaging of high density protein arrays.Overexpression of Anillin (ANLN) is correlated with colorectal cancer progression and poor prognosis.TOPK modulates tumour-specific radiosensitivity and correlates with recurrence after prostate radiotherapySubcellular localisation of anillin is associated with different survival outcomes in upper urinary tract urothelial carcinoma.Preoperative imaging markers and PDZ-binding kinase tissue expression predict low-risk disease in endometrial hyperplasias and low grade cancersCell-free measurements of brightness of fluorescently labeled antibodies.Infiltration of γδ T cells, IL-17+ T cells and FoxP3+ T cells in human breast cancer.Targeting the T-Lak cell originated protein kinase by OTS964 shrinks the size of power-law coded heterogeneous glioma stem cell populations.Overexpression of ANLN contributed to poor prognosis of anthracycline-based chemotherapy in breast cancer patients.ANLN functions as a key candidate gene in cervical cancer as determined by integrated bioinformatic analysis.
P2860
Q24313384-FCB79FD9-3E51-4E06-BC4C-3215616CC0E4Q28083506-3BC82160-817A-404B-8DED-2A6DF1C2B77BQ33784670-0A30FB20-C540-4864-BB85-6F38C82F3E13Q35828584-14824266-0AC3-44CD-8BA2-D761AD2FF4BAQ36105177-ED986FCC-38C9-439E-A543-DA2E31223750Q36198154-BC72406E-37F3-4814-8536-AF69457A5026Q36546506-90744E84-301B-4493-AECD-96676C7297A5Q37134340-D866A194-7067-4461-A7AE-54A3FBF4DDF3Q37269345-8ED9E3F6-40FB-47B3-A35C-51BF681BCB42Q37584289-7E2B8AD3-207E-4F80-BB98-6F6D14437D87Q38728416-BE8C10A0-278E-4D0F-8B55-D9BE6138FA25Q38945753-34C4D71D-FCBC-41CA-873B-471BAFCDFC2DQ38956409-89887957-3605-4DA7-8E1B-F4A7B5C137EBQ39124942-D9000EF4-3ED8-4B2A-B2F3-C2D5EFF9FADAQ40808611-D214DAA3-D156-4A23-8F99-03DACEC84B56Q41431230-17DEC178-DF2F-4B07-860B-0F48BD04DA78Q41620827-619A83AA-C68E-47FF-8E7B-272F2EC93AFBQ41878396-4253CD50-864F-442F-A860-54176A74CF5CQ41969550-14D19202-7302-4B0B-93BE-E3F70A08A64DQ47737173-F62D0235-3FB1-4D6E-B1B9-6CE7852DA04AQ49425250-05614E5E-D240-46BA-8DE7-A9A38CB55FBBQ51119330-0B951EBA-2DF1-43DD-9ADD-E73FA869ECD3Q52579365-75E31131-3265-4F1A-94C2-EA9F064F5EF7
P2860
Systematic antibody generation and validation via tissue microarray technology leading to identification of a novel protein prognostic panel in breast cancer.
description
2013 nî lūn-bûn
@nan
2013 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Systematic antibody generation ...... nostic panel in breast cancer.
@ast
Systematic antibody generation ...... nostic panel in breast cancer.
@en
Systematic antibody generation ...... nostic panel in breast cancer.
@nl
type
label
Systematic antibody generation ...... nostic panel in breast cancer.
@ast
Systematic antibody generation ...... nostic panel in breast cancer.
@en
Systematic antibody generation ...... nostic panel in breast cancer.
@nl
prefLabel
Systematic antibody generation ...... nostic panel in breast cancer.
@ast
Systematic antibody generation ...... nostic panel in breast cancer.
@en
Systematic antibody generation ...... nostic panel in breast cancer.
@nl
P2093
P2860
P50
P356
P1433
P1476
Systematic antibody generation ...... nostic panel in breast cancer.
@en
P2093
Amanda H McCann
Catherine M Kelly
Donal J Brennan
Elton Rexhepaj
Malcolm R Kell
Michael J Duffy
Patrick C O Leary
Roisin T Dolan
Sarah A Penny
P2860
P2888
P356
10.1186/1471-2407-13-175
P407
P577
2013-04-02T00:00:00Z
P5875
P6179
1028668934